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Abstract
Background: The populations of industrialised countries are ageing; as this occurs, those who
continue to use alcohol and illicit drugs age also. While alcohol use among older people is well
documented, use of illicit drugs continues to be perceived as behaviour of young people and is a
neglected area of research. This is the first published qualitative research on the experiences of
older drug users in the United Kingdom.
Methods: Semi-structured interviews were conducted in Merseyside, in 2008, with drug users
aged 50 and over recruited through drug treatment services. Interviews were recorded and
transcribed and analysed thematically. Only health status and health service contact are reported
here.
Results: Nine men and one woman were interviewed (age range: 54 to 61 years); all but one had
been using drugs continuously or intermittently for at least 30 years. Interviewees exhibited high
levels of physical and mental morbidity; hepatitis C was particularly prevalent. Injecting-related
damage to arm veins resulted in interviewees switching to riskier injecting practices. Poor mental
health was evident and interviewees described their lives as depressing. The death of drug-using
friends was a common theme and social isolation was apparent. Interviewees also described a
deterioration of memory. Generic healthcare was not always perceived as optimal, while issues
relating to drug specific services were similar to those arising among younger cohorts of drug users,
for example, complaints about inadequate doses of prescribed medication.
Conclusion: The concurrent effects of drug use and ageing are not well understood but are
thought to exacerbate, or accelerate the onset of, medical conditions which are more prevalent in
older age. Here, interviewees had poor physical and mental health but low expectations of health
services. Older drug users who are not in contact with services are likely to have greater unmet
needs. The number of drug users aged 50 and over is increasing in Europe and America; this group
represent a vulnerable, and in Europe, a largely hidden population. Further work to evaluate the
impact of this change in demography is urgently needed.
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Background
The world's population is ageing. In 1900, the global pop-
ulation was estimated to have only 1% of people aged 65
years and over, by 2000 this figure was 7%, and by 2050,
the estimated proportion will be 20% [1]. As our popula-
tions age, people who continue to use drugs and alcohol
age also. Projections from the United States of America
(USA), for example, suggest that the number of people
aged 50 and over who need treatment for drug and alco-
hol problems will increase from 1.7 million in 2000 to 4.4
million in 2020 [2], while estimates from Europe suggest
that the number of people aged 65 and over needing treat-
ment for such problems will more than double between
2001 and 2020 [3]. In the United Kingdom (UK), research
using established monitoring systems has shown that the
proportion of drug users aged 50 and over in contact with
specialist drug services in Cheshire and Merseyside (the
only area of the country to have collected data on drug
treatment clients consistently since 1998 and therefore
the only area able to monitor demographic changes) has
increased between 1998 and 2004/05 from 1.5% to 3.6%
(P < 0.001) and 1.9% to 3.2% (P < 0.001) for men and
women respectively. Furthermore, the proportion aged 40
to 49, potential older drug users of the future, increased
from 8.1% in 1998 to 19.6% in 2004/05 [4].
A prospective cohort study undertaken in the USA demon-
strated that older drug users have levels of morbidity con-
siderably higher than the general population [5], while
qualitative research also completed in the USA demon-
strated that they experience loneliness, stress and fear of
victimisation [6]. The use of illicit drugs is, however, still
largely perceived to be behaviour of the young and, con-
sequently, continues to be a neglected area of research [7].
In particular, there has to date, and to the best of our
knowledge, been no qualitative research published on the
experiences of older drug users in the UK. Information
relating to what drugs older people in the UK use, the rea-
sons for initiating or continuing drug use and the specific
health and treatment needs of this group of people is, at
present, lacking in the UK; our understanding can not be
conceptualised using data from the USA due to cultural,
legal and attitudinal differences between the two coun-
tries, and differences in the manner in which healthcare is
delivered [8].
The aim of this present study was to undertake an investi-
gation into issues salient to older drug users. More specif-
ically, the study aimed to identify substance (drug and
alcohol) use, self-reported health status and contact with
generic and specialist health services of a cohort of older
drug users in contact with specialist drug treatment serv-
ices. Here we define older drug users as those aged 50 and
over.
Methods
Qualitative research was undertaken using semi-struc-
tured interviews with prompts to capture older people's
experiences across the life course. These interviews cov-
ered a range of topics but only results pertaining to health
status and health service contact, plus brief contextual
data, are presented here. While the interviewer had a
number of pre-determined topics to cover, the interviewer
was sensitive to the interviewee and their narrative, allow-
ing for the exploration of topics that arose spontaneously,
in order to enhance the qualitative information obtained.
Interviews were conducted by the same researcher (LP) to
ensure consistency and all were taped and transcribed. LP
also provided additional information to enhance the
quality of the transcriptions. Approval for this study was
granted by the Liverpool John Moores University Ethical
Committee. Each participant received a £10 shopping
voucher in compensation for their time dedicated to the
study.
Recruitment
Staff working in voluntary sector, specialist drug treatment
services in Merseyside were asked to identify clients within
their care aged 50 and over and to introduce the study to
them. People who expressed a willingness to participate
were given an information sheet to take with them and the
member of staff contacted the research team with the cli-
ent's name and contact telephone number. A member of
the research team (LP) made contact with the potential
participant and organised a convenient time and place for
the interview to occur. Prior to the interview, each poten-
tial participant was given another information sheet, and
a consent form. Full informed consent was obtained,
including specific consent to use anonymised quotes, and
it was explained that participation would not influence
their ongoing medical care. Interviews were conducted
between 16th January and 22nd February 2008. Recruit-
ment continued until no new major themes were identi-
fied.
Analysis
Transcripts were scrutinised by all four authors, who ana-
lysed them using thematic analysis [9]. Each member of
the research team initially independently identified broad
themes which were given codes; these were then discussed
and agreed by the research team. Each transcript was then
read again by all authors, were coded, and passages relat-
ing to each theme were grouped together. Themes
included drug use, health, quality of life, lifestyle and
employment, relationships and social networks and use
of services.
Reliability and validity
The first three interviews were used to establish the feasi-
bility of recruitment, inclusion criteria and to test theBMC Geriatrics 2009, 9:45 http://www.biomedcentral.com/1471-2318/9/45
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methods of data collection. No changes to the interview
schedule or prompts were made but we reduced the min-
imum age from 60 to 50 years because it proved difficult
to recruit a sufficient number of people aged over 60. The-
matic analysis showed no difference in the themes and
sub-themes between these pilot interviews and the data
from all other interviews and so the pilot interviews have
been included in the results. Where interviewees provided
contradictory or revisionist statements, the interviewer
(LP) sought clarification in order to enhance the validity,
accuracy and consistency of responses and our under-
standing of their discourse. Reliability of the analysis was
assured by members of the team reading and re-reading
transcripts, and by discussion and agreement of the
themes and sub-themes. The measures described here are
standard verification techniques for establishing quality,
validity and rigour in qualitative research [10,11].
Results and Discussion
Context, demography and substance use
Nine men and one woman were interviewed in a range of
settings; within a doctor's surgery (n = 2), at home (n = 2),
in a care home (n = 1) and at a drug treatment service (n
= 5). The ages of interviewees ranged from 54 to 61 years.
Six were single and four were divorced at the time of the
interview, with two living with a male friend who acted as
a carer, one more who lived next door to a friend/male
carer and another who shared their accommodation with
other drug users. Their accommodation varied; some lived
in a hostel, others in their own home (council house, flat
or housing association bed sit), one man lived in a care
home and another lived in a caravan.
All but one interviewee had started substance use when in
their adolescent, or early adult, years but there was no sin-
gle pattern to drug initiation; drugs first used included
alcohol, cannabis, lysergic acid (LSD), amphetamine,
morphine hydrochloride, heroin, 'speedballs' (heroin in
combination with a strong stimulant, usually cocaine)
and (psilocybin-containing) mushrooms and people sim-
ply switched drugs according to availability. For these
people, drug use across the life course was divided into
three camps, with some interviewees ceasing drug use for
many years at a time, some using drugs intermittently
with short periods of abstinence, while others followed a
course of near continual consumption. Conversely, one
interviewee was a late onset user, having commenced
drinking aged 30 (which progressed into problematic
drinking) and drug use (heroin) aged 46. Every inter-
viewee was, or had been, a problematic drug user (cur-
rently defined in the UK as a user of opiates and/or crack
cocaine [12]). Every interviewee had used heroin during
their lives and some were still using this drug at the time
of interview; many were in receipt of a methadone pre-
scription as part of opiate substitution therapy. Six people
also reported a history of cocaine and/or crack cocaine
use. Some interviewees acknowledged that they had
injected drugs or inferred that this was the case by discuss-
ing injection-related health consequences. A more
detailed discussion of substance use and other themes
arising from this study will be presented elsewhere.
Physical health
The effects of the interaction between drug use and those
processes that characterise ageing are poorly understood.
However, there is evidence to show that drug use exacer-
bates, or accelerates the onset of, medical conditions
which are more prevalent in older age. Stimulant use, for
example, can lead to cardiovascular complications in
younger drug users, while longer term use may increase
the likelihood of premature atherosclerosis, ventricular
hypertrophy and cardiomyopathy. Drug use has also been
associated with an earlier onset on diabetes, while neuro-
logical disorders, respiratory disorders, cancer and other
age associated diseases may also all be worsened by drug
use [13]. Furthermore, the disorientating or hallucinating
effects of some psychoactive drugs increase the risk of acci-
dents and falls, particularly in combination with pre-
scribed or over-the-counter medications [13,14]. Falls are
a major cause of disability and mortality in older people
[15] and can be presumed to occur even more frequently
among those who use psychoactive drugs including alco-
hol.
Our interviewees reported a high level of physical morbid-
ity; circulatory problems, respiratory problems, pneumo-
nia, diabetes, hepatitis and liver cirrhosis. Overdose and
injuries also featured in their narratives. Summarising,
one man stated; "I'm... handicapped to the extent of can't go
out, suffer with arthritis in the right leg and lower back, blind
in one eye, suffer hepatitis C....". Hepatitis C infection, con-
tracted by injecting drug users through sharing contami-
nated drug injecting and/or preparation equipment [16],
was a common theme, with half of those interviewed stat-
ing they were infected with the virus. Despite being a seri-
ous infection, progressing to cirrhosis, end stage liver
disease and, in about one to five percent of those chroni-
cally infected, hepatocellular carcinoma [17], a synthesis
of qualitative research demonstrated that drug users of all
ages tend to see hepatitis C as somewhat of an inevitabil-
ity of injecting, that being infected is normal and that it is
physically benign, particularly relative to HIV [18]. This
perception of its benignity is presumably even greater
among those older drug users who contracted this infec-
tion many years previously and have experienced no
adverse consequences of long term infection. Certainly
our interviewees did not perceive their infection to be
problematic;BMC Geriatrics 2009, 9:45 http://www.biomedcentral.com/1471-2318/9/45
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"I've never really had any serious illnesses.... I forgot the hep C
y'know. I've had no symptoms. I haven't been sick or anything
y'know, but I've got the virus".
There are many factors which influence the aetiology of
hepatitis C infection and its impact on liver function and
drug users of all ages are infected with the virus in the UK.
However, those older drug users who contracted the virus
many years previously may be at an advanced stage of dis-
ease progression. Furthermore, younger age at the com-
mencement of treatment is one positive predictor of
success in clearing the virus [19] and healthcare services
will need to be prepared to care for older drug users who
may be disproportionately affected by treatment failure.
Treatment services need also be aware of the wider deter-
minants impacting on the likelihood of older drug users
adhering to treatment and in particular the role of social
support in coping with the relatively long and unpleasant
nature of hepatitis C treatment [20]. Qualitative research
from the USA reported that older drug users had severed
links with non-drug using family and friends over the
years of drug taking [6], a premise supported by the cur-
rent research. For older drug users with little or no family
support, the involvement of services to support a person
while undergoing treatment will play an important role
[20].
The high proportion of interviewees with hepatitis C
reflects findings from the USA, where medical examina-
tions of 108 older heroin-dependent men (mean age 58.4
years) showed that 95 percent of their subjects had been
exposed to the hepatitis C virus, while more than half
were found to have abnormal liver function; these rates
were much higher than found in the general population
[5]. In recent years, the enormity of the UK's hepatitis C
epidemic has been evidenced through a number of
sources, with the Health Protection Agency consistently
citing it as the most significant infectious disease affecting
people who inject drugs [19]. There are currently an esti-
mated 330,000 problematic drug users (users of opiates
and/or crack cocaine) in England and 120,000 current
injectors of these substances [21] plus many others who
are ex-drug injectors. According to Health Protection
Agency estimates, approximately half of all current drug
injectors are infected with hepatitis C, and both incidence
and prevalence continue to rise [19]. As the already ageing
cohort of drug users [4] age further, those infected with
the virus will gradually develop symptoms of the infection
and the full impact of hepatitis C infection among current
and ex- drug injectors will become apparent. Currently,
the burden of drug related chronic conditions such as
hepatitis C, which disproportionately affect older drug
users compared to their younger counterparts, is not being
fully recognised because such deaths are not classified
under UK or European definitions as drug related deaths
and are therefore not counted in official figures [22,23].
Four interviewees discussed vein damage as a conse-
quence of long term intravenous drug use and the fact that
this made continuing to inject in their arms difficult. Con-
sequently, interviewees had switched to more risky inject-
ing practices (which included injecting into their groin
and feet [24]) to overcome problems of gaining venous
access, despite being aware of the elevated risk such prac-
tices convey;
"It's harder now to inject because your veins. Your veins sort of
go y'know... I've been injecting in my foot, which is stupid
really, y'know. You can catch an infection and you could end
up losing your leg".
One man talked of having been hospitalised for deep vein
thrombosis (a blood clot which forms in a deep vein), a
recognised potential consequence of intravenous drug use
for all ages [24]. However, deep vein thrombosis becomes
more likely among older injectors, particularly for those
who have been heavy smokers, because in addition to the
damage to veins caused by injecting, the ageing process is
associated with changes in blood pressure, venous valve
deterioration and reduced regenerative process [25];
healthcare staff should ensure that older drug users, espe-
cially those who smoke, are aware of this increased risk.
Only three of the 10 interviewees complained of having
respiratory problems despite research from the USA show-
ing heroin-dependent males to have high rates of obstruc-
tive lung disease [5]. This difference may be due to the
men recruited in the USA study being predominantly
smokers of heroin while the majority of those interviewed
in this study discussed injecting as their mode of drug
administration. One man interviewed in the present study
was a heavy crack cocaine smoker and complained of res-
piratory problems and how this affected him; "I get out of
breath easy. I absolutely panic then". A second crack cocaine
smoker, who had experienced bronchial pneumonia
twice, concurred; "it's tender inside and when I breathe I can't
breathe hard cos it hurts like hell". The link between smoking
any substance, including cigarettes, and respiratory com-
plications is well known. Clinical guidelines recognise the
high prevalence of smoking-related disorders among drug
users, and the importance of offering smoking cessation
interventions for smokers [26].
The people interviewed in the present study had used a
variety of drugs across their life course, including alcohol,
and had complex physical health needs. Drug use into
older age can be seen as accelerating the physical health
changes commonly associated with ageing. Furthermore,
immunosenescence, the notion that there is an age relatedBMC Geriatrics 2009, 9:45 http://www.biomedcentral.com/1471-2318/9/45
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dysfunction of the immune system which leads to
enhanced risk of infection [27], is an issue for all older
people but will presumably have greater consequences for
those older drug users who have experienced a lifetime of
deprivation and poor environmental condition, making
them particularly susceptible to opportunistic diseases
such as pneumonia and other infections when compared
to younger drug users or older people who do not use
drugs [22]. Moreover, chronic poor nutrition will com-
pound the physical problems arising from concomitant
drug use and ageing; "I don't know but I think I'm seven stone
now... I only have chips seven days a week". Consequently,
for older drug users who have survived overdoses and
other negative acute effects of drug use, it appears to be the
longer term effects of drug use that become important in
terms of their impact on physical health. Healthcare serv-
ices, including drug specific services therefore need to rec-
ognise the impact of chronic multiple drug use on the
physical health of older drug users and offer a package of
care that addresses the person's general health in addition
to the provision of drug treatment [22].
Mental health
The links between mental health and substance use are
complex but well documented and a high prevalence of
co-morbidity exists. One study conducted in the UK, for
example, reported that 44 percent of patients in commu-
nity mental health services reported problem drug use
and/or harmful drinking in the previous year, while 75
percent of people in contact with substance misuse serv-
ices reported a psychiatric disorder during the same
period of time [28]. Psychological conditions, including
depression, loneliness, anxiety, memory problems, cogni-
tive impairment, dementia and confusion become more
prevalent in older age [15]. Ageing may therefore be asso-
ciated with further elevation in the prevalence of mental
health disorders in a population where the prevalence of
such conditions is already considerably higher than that
of the general population. Furthermore, prolonged use of
some psychotropic drugs for example the benzodi-
azepines, is actually associated with depression and cogni-
tive decline [13]. Under-detection of such conditions
including depression is relatively common among all
older people [15] but may be a more significant issue for
drug users because a considerable proportion do not seek
treatment in services where screening for such disorders
occurs [29].
Four interviewees commented that, during the course of
their lives, their drug use had started, escalated or resumed
following significant stressful events. For example, when
discussing a relationship break up one man said; "You
reach a point in our life, different points in your life where
you've got a lot of stress and the easiest thing in the world is to
say 'oh fuck it'. And once you've said that, if you're a drug user,
a drug abuser, once you've said that, you're on the rocky road
to destruction again". Across the life course, feeling sad or
depressed due to stressful life events accounted for the rea-
son why some of our interviewees recommenced drug use
following long periods of abstinence and that using drugs
was a means to forget about worries; That's all we do any-
way, just take it [heroin] and just mong [be relaxed and doc-
ile]  for the day like and forget about your worries and
everything, got problems and you forget all that. Things like
that; it's the reason why people take it like".
These findings highlight the need for healthcare services
to be vigilant for drug and alcohol use by older adults,
even among those who have ceased use for many years,
while social support services for older people should also
be aware of the need to screen people for drug and alcohol
use, particularly those in contact during times of stress
such as occurs following bereavement or relationship fail-
ure. However evidence from the USA suggests that health-
care professionals are currently poor at diagnosing
substance use among older people [30] possibly because
of a lack of awareness that substance use among older
adults occurs. Furthermore, the current screening tools for
drug use, for example the Diagnostic and Statistical Man-
ual of Mental Disorders IV for substance abuse, have not
been validated for older populations [13], furthering
problems of diagnosis.
Interviewees talked in terms of a life using drugs being
depressing; "It's a depressing life y'know. It's no good" and
how life not using drugs (where this was the case) had
been more positive; "I was high on myself y'know [when not
using drugs]. I'd look in the mirror and see somebody I loved.
I don't any longer.... I can't see a road back to loving myself
again". Conversely however, two interviewees were com-
paratively content with life at the time of the interview,
with one recognising a link between reduced drug use and
improvements in mood; "The ale was just a depressant
wasn't it? And the heroin was just a depressant. Just making
myself lower and lower all the time, wasn't I? Now I'm off the
two of them I'm happy as a lark".
The loss of friends, predominantly through drug use, was
a common theme through the interviews and was also
associated with feelings of sadness and depression; this
finding is unsurprising in light of extensive evidence to
show that strong social networks have a positive effect on
the health of older people, particularly on their mental
health [31]. Loss of friends, isolation and changes in
social networks are issues experienced by many older peo-
ple [32] but this is intensified among drug users and
occurs earlier in life because rates of mortality are higher
than in the general population [33]. Furthermore, older
drug users tend to associate exclusively with other drug
users, having severed links with non-drug using familyBMC Geriatrics 2009, 9:45 http://www.biomedcentral.com/1471-2318/9/45
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and friends over the years of drug taking [6], a premise
supported by the findings of our interviews. Conse-
quently, survivors are left alone or in contact with younger
drug users from a different peer group. One particularly
erudite man who had recently experienced the last of his
friends die said;
"It's made me extremely depressed in as much as the few that
were left are people I could talk to and at least there's consola-
tion in company if its good company... [now] the only company
I could find if I wanted to would be people who are younger and
on that totally different scene, and like I say, I have nothing in
common with them... Consequently find myself quite lonely at
times".
These results confirm findings from the USA, which high-
lighted isolation and loneliness as important issues for
older drug users [6]. For one interviewee, isolation was
heightened by being morbidly obese and unable to walk
more than a few steps; a physical state derived from
cocaine-induced agoraphobia and inactivity;
"But I got so heavy with it [cocaine use] that I ended up getting
agoraphobia cos I spent, must have been nearly four years in
bed, just in bed...I think it was the four years what I ended up
spending in bed that sort of got me into the state of putting on
so much weight".
Furthermore, the isolation experienced by some older
people may be exacerbated among older drug users by
drug-related paranoia, experienced by three interviewees;
"I don't like going to pubs. I always get paranoid... Everybody's
looking at me... Drugs do it to you".
Younger drug users also experience friends dying (particu-
larly through acute drug toxicity) but they may be some-
what cushioned from the effects by having larger social
networks and more opportunities to make new friends.
Younger drug users are also more likely to be in contact
with their families. As older drug users die, the pool of
peers grows ever smaller for those older drug users left
behind. Of interest to this discussion, three interviewees
appeared to have overcome this problem by forming new
support structures, through developing friendships with
much younger drug users who acted as carers. As the
mobility, physical and mental capacity of older people
fade they need to develop contacts with younger people to
secure emotional and practical support. This is a consider-
able challenge for those without children [31], yet it
appears that symbiotic alliances between older drug users
and younger drug users develop out of this practical neces-
sity. For example, one interviewee who had no family, had
seen most of his friends die, who had recently had a stroke
and who rarely left his house relied heavily on a much
younger friend for assistance with daily tasks like collect-
ing shopping, his benefits and his methadone prescrip-
tion and doing the cooking. His younger friend, who was
present during the interview comments "he helps me as I
help him. We're good for each other". The younger drug user
was not the focus of the interview and how exactly he ben-
efited from this relationship was not explored although he
did say that he enjoyed the company of the older drug
user and suggested that he used his older friend's home as
a preferable place to use drugs despite having his own
place to live; "I'd rather do it [use drugs] here [older drug
user's home] than some lavatory somewhere". Furthermore,
the interviewee alluded to the fact that his younger friend
might benefit financially be referring to his own social
security payments in relation to "the money we get". These
findings show a high level of adaptation and resilience
among older drug users in relation to social support and
we recommend further research should explore these rela-
tionships in more detail.
In general, ageing is associated with a decline in memory
[34] and interviewees were specifically asked about this.
Problems with memory, confirmed by six interviewees,
were particularly related to what they termed 'short term'
memory, for example, putting an object down and not
remembering where it was placed a few minutes later. Of
those who commented, two felt that age had contributed
to their lack of memory, while most felt this was more
associated with drug and alcohol use; "I can only put it
down to just, down to drug abuse and drink abuse, really. I
can't really put it down to anything else". The older inter-
viewee detailed in the paragraph above had a significantly
impaired memory and relied greatly upon his younger
male friend/carer. Of particular importance, the inter-
viewee relied upon this friend to remember to collect his
methadone prescription, a drug which the older inter-
viewee needed to consume daily. We know that high lev-
els of alcohol consumption result in memory impairment
due to thiamine deficiency, and the risk of even mild cog-
nitive impairment in later life is significantly elevated
among those who consume alcohol frequently compared
to those who drink infrequently [35]. Continuing drug
use into older age may carry particular risks in terms of the
concurrent effect on the brain; the brain changes in a
number of ways across the life course, and the effect of
these changes when combined with substance use are not
well understood [13].
Health service contact
Interviewees discussed contact with both generic and spe-
cialist services. Care received in hospitals was not always
optimal and some who had received care within this set-
ting perceived hospital staff to treat them differently
because they were drug users; "Like normally when you go
into hospital and they find out that you're a heroin addict, they
normally don't want to know you". One man found his expe-BMC Geriatrics 2009, 9:45 http://www.biomedcentral.com/1471-2318/9/45
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rience of hospital particularly humiliating with staff
assuming he had hidden drugs within the toilet; "And they
come in one night and says they couldn't find the toilet I put it
[the drugs] in. In front of everybody and they put it in one of
them big needles and squirted into my mouth in front of every-
body. Makes you feel that big". In another instance, a con-
frontation caused by the misdiagnosis of a broken leg
resulted in the police being called;
"They didn't diagnose it as a broken leg. They said there was
nothing on the x-ray and I was in agony, y'know, with a walk-
ing stick and a broken leg. And I had to go three times to the
hospital y'know... And I went back and they missed it again.
And by then they're getting the police to throw me out the hos-
pital".
The above negative accounts of experiences were coun-
tered by descriptions of instances of being cared for by
healthcare staff with compassion and sensitivity; "the staff
on that ward, they were good to me... I was happy in there. I
could have stayed in there".
The de facto national service framework for drugs and alco-
hol highlights the importance of integrated care pathways
and including non-drug specific services such as hospitals
in the treatment of drug users; in particular in screening
for drug use and referral into specialist services [36]. While
this integration is important for drug users of all ages,
older drug users are more likely than their younger coun-
terparts to be in contact with hospitals for a number of
general chronic conditions, in addition to those specifi-
cally associated with their drug use. Hospitals therefore
offer additional opportunities for screening and referral
for older drug users and it is important that stigmatisation
does not deter them from seeking hospital assistance.
Finally, with respect to hospitals, one man complained
that doctors would not prescribe his dying friend, also a
drug user, analgesia because he was using methadone as
part of his drug treatment. The safe use of opioids to man-
age pain does present a challenge, but there are a number
of reasons why drug users may have greater needs than
non-drug users regarding pain management, and drug use
per se should not preclude a practitioner prescribing an
opioid. In particular, people with a history of drug use
that need palliative care, should not be denied opioids to
manage pain, and often these will need to be given in con-
junction to drugs received as part of substitution therapy
such as methadone [37]. While mentioned by a single
interviewee with only indirect experience, pain manage-
ment and palliative care are likely to become important
issues as a growing number of drug users reach older age
and stigma and discrimination should not be allowed to
affect care.
Other non-drug related care discussed by interviewees
included generic rehabilitative treatment and this tended
to be perceived as poor. The man who presented at hospi-
tal with a broken leg, for example, bemoaned; "I can't get
a physiotherapist to come out. Or she did and she says 'oh that's
great progress'. Just to tick me off the list y'know". A second
man, who found the impaired verbal skills that followed
his stroke very frustrating, had been offered, but had not
accepted, speech therapy. He appeared to lack the under-
standing that such therapy could be advantageous; "I think
my stroke will get better on its own if it's going to get better. I
really do. I don't think anybody can do anything about it". It is
a well accepted phenomenon that the least advantaged in
society often make the least demands of specialist health
services [38] despite their needs and our results confirm
this; interviewees tended to have poor health but low
expectations of specialist health services.
With respect to the views expressed by the interviewees
about their care within drug services, no issues unique to
older drug users emerged except for one man who said of
his recent experience in residential rehabilitation that he
was "a bit embarrassed, y'know, being the oldest one" and a
second interviewee commented that there were many
more services available to drug users now compared to
when he had been younger. Interviewees were compli-
mentary about outreach staff (who visit drug users in their
homes and usually make few demands of their clients)
and non-clinical drug service staff; "This place [drug serv-
ice] is sound [great]. They're all sound in here. Like the girl
who I see, [member of staff's name], she's brilliant her...
nothing bad to say about her". However, some complained
about the doctors. One man, for example, was distressed
and complained that a doctor would not increase his pre-
scription of methadone ampoules, only his methadone
'linctus' which he complained made him vomit. Doctors
in the UK are advised to prescribe methadone in an oral
formulation and not injectable ampoules [26] because
injecting carries a greater risk of dying from acute drug tox-
icity, and this situation demonstrates the difficulties clini-
cians face in terms of offering care in accordance with
clinical guidelines, while still meeting the needs of their
clients.
Conclusion
Qualitative research makes no claims to generalisability;
this study was carried out with white, predominantly male
drug users in Merseyside, UK and included only ten peo-
ple. Furthermore, these drug users were recruited through
drug services and were all, or had been, problematic drug
users (users of opiates and/or crack cocaine) and may not
be representative of drug users not in contact with such
services or users of different drugs. However, these find-
ings add to knowledge and understanding of the physical
and mental health of older drug users and their percep-BMC Geriatrics 2009, 9:45 http://www.biomedcentral.com/1471-2318/9/45
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tions of healthcare. We show that in general, drug users
aged over 50 have poor levels of physical and mental
health; our findings support the premise that substance
use into older age exacerbates, or accelerates the onset of,
medical conditions which are more prevalent in older age.
Consequently, in relation to their needs, our interviewees
appear to fit into the 'frail older people' category which is
normally associated with people of a much older age [15].
We also highlight cases where drug users perceive their
generic healthcare to be sub-optimal and conclude that
older drug users, like other lower socio-economic groups,
have relatively poor expectations of specialist healthcare.
How drug services adapt to this ageing population of drug
users and how geriatric services adapt to an increasing
number of older people who use drugs need urgent con-
sideration. People interviewed in the present study were
recruited through drug services and those older people
who are drug dependent and not in contact with services
may be presumed to have even greater unmet needs.
Ageing drug users continue to be a neglected sub-group in
the UK, largely because of societal attitudes about the
behaviours deemed relevant to older people. The recently
published national drug strategy [12] for example, failed
to mention this change in demographic nor how services
should respond to this challenge. This issue is not unique
to the UK; the number of older drug users living in the UK
and other developed nations will rise [7] and further work
is urgently needed to evaluate what challenges this change
in demographic presents.
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